Our experience collaborating with oncology and immunology leaders in the pharmaceutical and biotech space has revealed the numerous challenges in every stage of drug development. From target candidate identification to pharmacovigilance, nearly every stage relies on harmonized, well-curated databases to move forward with confidence. But that's not the whole story; advanced, integrated analyses are vital to truly unlock their value.

Customized Analytical Solutions: One size doesn’t fit all. That’s why we create custom project solutions tailored to discover and develop novel cancer therapeutics that matter to you. At QIAGEN Digital Insights Professional Services, we help you extract reliable insights from your multiomics datasets, including genomics, transcriptomics, proteomics, and single-cell and spatial expression profiling data, by combining robust, manually curated databases with the expertise of our scientific consultants.

Learning Objectives:  

1. Assisting clients in identifying alternative indications or disease conditions for existing drugs by providing mechanistic insights that link new and primary indications.  

2. Using context clues from spatial transcriptomics, single-cell transcriptomics and systems biology analyses to trace microenvironmental variations within tumors and understand immune cell recruitment patterns.  

3. Power immunogenicity analyses for neo-antigen discovery with public and proprietary somatic and RNA-seq datasets.